Torrado C, Nassif Haddad E, Somaiah N, Msaouel P, Lazar A, Piha-Paul S
J Immunother Precis Oncol. 2025; 8(2):113-120.
PMID: 40070529
PMC: 11896019.
DOI: 10.36401/JIPO-24-28.
Di J, Alhaidary A, Wang C, Liu J, Wei S, Valentino J
Biomedicines. 2024; 12(8).
PMID: 39200173
PMC: 11351216.
DOI: 10.3390/biomedicines12081709.
Cao J, Liu Y, Lu C
Gland Surg. 2024; 13(6):1116-1125.
PMID: 39015712
PMC: 11247582.
DOI: 10.21037/gs-24-77.
Arai S, Tomioka R, Ueda Y, Shimizu A, Okamoto I, Tsukahara K
Cancer Diagn Progn. 2024; 4(3):370-378.
PMID: 38707725
PMC: 11062161.
DOI: 10.21873/cdp.10334.
Bell D
Head Neck Pathol. 2024; 18(1):2.
PMID: 38315310
PMC: 10844182.
DOI: 10.1007/s12105-023-01608-z.
Histopathological features of giant mediastinal tumors-a literature review.
Brcic L, Roden A
Mediastinum. 2023; 7:37.
PMID: 38090032
PMC: 10713243.
DOI: 10.21037/med-23-23.
Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice.
Ma C, Jin Y, Wang Y, Xu H, Zhang J
Front Oncol. 2023; 13:1231420.
PMID: 37781207
PMC: 10540843.
DOI: 10.3389/fonc.2023.1231420.
BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications.
To K, Xing E, Larue R, Li P
Molecules. 2023; 28(7).
PMID: 37049806
PMC: 10096006.
DOI: 10.3390/molecules28073043.
Rare molecular subtypes of lung cancer.
Harada G, Yang S, Cocco E, Drilon A
Nat Rev Clin Oncol. 2023; 20(4):229-249.
PMID: 36806787
PMC: 10413877.
DOI: 10.1038/s41571-023-00733-6.
Nuclear protein in testis carcinoma of the lung.
Chen J, Li M, Lu H
Transl Oncol. 2023; 30:101640.
PMID: 36780749
PMC: 9947104.
DOI: 10.1016/j.tranon.2023.101640.
Translocations and Gene Fusions in Sinonasal Malignancies.
Larkin R, Hermsen M, London Jr N
Curr Oncol Rep. 2023; 25(4):269-278.
PMID: 36753024
PMC: 10316133.
DOI: 10.1007/s11912-023-01364-x.
Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.
Chen M, Chen X, Zhang Y, Wang W, Jiang L
J Cancer Res Clin Oncol. 2023; 149(9):6361-6370.
PMID: 36752907
DOI: 10.1007/s00432-023-04621-5.
Case report: NUT carcinoma with MXI1::NUTM1 fusion characterized by abdominopelvic lesions and ovarian masses in a middle-aged female.
Jiang H, Wang C, Hou Z, Wang Y, Qiao J, Li H
Front Oncol. 2023; 12:1091877.
PMID: 36741693
PMC: 9890191.
DOI: 10.3389/fonc.2022.1091877.
Structural mechanism of BRD4-NUT and p300 bipartite interaction in propagating aberrant gene transcription in chromatin in NUT carcinoma.
Yu D, Liang Y, Kim C, Jaganathan A, Ji D, Han X
Nat Commun. 2023; 14(1):378.
PMID: 36690674
PMC: 9870903.
DOI: 10.1038/s41467-023-36063-5.
NUT Carcinoma of the Lung：A Case report and Literature Analysis.
Zhao R, Hua Z, Hu X, Zhang Q, Zhang J, Wang J
Front Oncol. 2022; 12:890338.
PMID: 35903693
PMC: 9321640.
DOI: 10.3389/fonc.2022.890338.
NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics.
Moreno V, Saluja K, Pina-Oviedo S
Front Oncol. 2022; 12:860830.
PMID: 35372003
PMC: 8966081.
DOI: 10.3389/fonc.2022.860830.
Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.
Lejman M, Chalupnik A, Chilimoniuk Z, Dobosz M
Int J Mol Sci. 2022; 23(5).
PMID: 35269896
PMC: 8911213.
DOI: 10.3390/ijms23052755.
Unclassified Neuroendocrine Tumor with a Novel CHD4::AFF2 Fusion: Expanding the Family of AFF2-Rearranged Head and Neck Malignancies.
Miller D, Palsgrove D, Rijal A, Hathuc V, Chernock R, Gagan J
Head Neck Pathol. 2022; 16(3):928-933.
PMID: 35218513
PMC: 9424404.
DOI: 10.1007/s12105-022-01432-x.
The oncogenic fusion landscape in pediatric CNS neoplasms.
Roosen M, Ode Z, Bunt J, Kool M
Acta Neuropathol. 2022; 143(4):427-451.
PMID: 35169893
PMC: 8960661.
DOI: 10.1007/s00401-022-02405-8.
Immunotherapy and Targeting the Tumor Microenvironment: Current Place and New Insights in Primary Pulmonary NUT Carcinoma.
Li X, Shi H, Zhang W, Bai C, He M, Ta N
Front Oncol. 2021; 11:690115.
PMID: 34660264
PMC: 8515126.
DOI: 10.3389/fonc.2021.690115.
